Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) P
about
Periprocedural antithrombotic therapy during various types of percutaneous cardiovascular interventionsEmerging Tools for Stroke Prevention in Atrial FibrillationA Patient With Asymptomatic Cerebral Lesions During AF Ablation: How Much Should We Worry?Impact of periprocedural anticoagulation strategy on the incidence of new-onset silent cerebral events after radiofrequency catheter ablation of atrial fibrillation.Real Data on Effectiveness, Tolerability and Safety of New Oral Anticoagulant Agents: Focus on Dabigatran.Rationale and design of AXAFA-AFNET 5: an investigator-initiated, randomized, open, blinded outcome assessment, multi-centre trial to comparing continuous apixaban to vitamin K antagonists in patients undergoing atrial fibrillation catheter ablationTransesophageal vs. intracardiac echocardiographic screening in patients undergoing atrial fibrillation ablation with uninterrupted rivaroxaban.Thrombotic cardiac tamponade after transseptal puncture.Use of dabigatran vs. warfarin with low-molecular-weight heparin bridging in catheter ablation for atrial fibrillation patients with a low CHADS2 scorePerioperative management of patients on direct oral anticoagulants.Stroke rates before and after ablation of atrial fibrillation and in propensity-matched controls in the UK.[Interventional treatment for paroxysmal atrial fibrillation : which is the optimal ablation approach?].Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants versus Vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-Analysis[Catheter ablation and the complications].Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation.Influence of Clinical Parameters and Anticoagulation on Intraprocedural Cerebral Microembolic Signals during Pulmonary Vein IsolationMeta-analysis of efficacy and safety of apixaban and uninterrupted apixaban therapy compared to vitamin K antagonists in patients undergoing catheter ablation for atrial fibrillation.Right ventricular thrombus formation in a patient with arrhythmogenic right ventricular dysplasia following radiofrequency ablationCurrent strategies to minimize the bleeding risk of warfarin.Efficacy and safety of rivaroxaban compared with vitamin K antagonists for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis.Warfarin versus dabigatran etexilate: an assessment of efficacy and safety in patients with atrial fibrillation.Management of atrial fibrillation: What is new in the 2014 ACC/AHA/HRS guideline?Periprocedural Management of New Oral Anticoagulants in Atrial Fibrillation Ablation.Dabigatran for the prevention and treatment of thromboembolic disorders.Rivaroxaban in the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation: Clinical Implications of the ROCKET AF Trial and Its Subanalyses.What's new in stroke? Phase III randomized clinical trials of 2012-2014.Apixaban, rivaroxaban, and dabigatran use in patients undergoing catheter ablation for atrial fibrillation using the second-generation cryoballoon.Evolving cardiovascular uses of direct-acting oral anticoagulants: a paradigm shift on the horizon?Management of Periprocedural and Early Pericardial Effusions With Tamponade Following Ablation of Atrial Fibrillation With Uninterrupted Factor Xa Inhibitors: A Case Series.Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1.Safety of Anticoagulation Interruption in Patients Undergoing Surgery or Invasive Procedures: A Systematic Review and Meta-analyses of Randomized Controlled Trials and Non-randomized Studies.Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery.A tailored treatment strategy: a modern approach for stroke prevention in patients with atrial fibrillation.Anticoagulation Bridge Therapy in Patients with Atrial Fibrillation: Recent Updates Providing a Rebalance of Risk and Benefit.Are Some Anticoagulants More Equal Than Others? - Evaluating the Role of Novel Oral Anticoagulants in AF Ablation.Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary.Management of Patients on Non-Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association.Thromboembolic and bleeding risks in patients undergoing atrial fibrillation ablation: oral anticoagulation perspectives.Influence of periprocedural anticoagulation strategies on complication rate and hospital stay in patients undergoing catheter ablation for persistent atrial fibrillation.Network meta-analysis of efficacy and safety of competitive oral anticoagulants in patients undergoing radiofrequency catheter ablation of atrial fibrillation.
P2860
Q26740181-082FBC0F-48E4-4757-ACD2-457BBBDD0D42Q26765023-9EC8082B-D205-4163-8AF8-7EA398B41FD8Q28077388-0352088A-7EF3-43A9-9213-EB083DD1FA30Q30315374-0668793B-A33A-4DE7-A70F-FC298BE8E4D1Q31098679-7E231035-78DB-45BC-99F7-51C50F8AE368Q31157420-873C9D0A-D44F-444F-88A8-C293767D864CQ32177661-B3686C9E-CAD0-408B-B35A-B86E8DC28A6CQ33639890-3701B877-5C33-4187-AF8A-8364A2237531Q33685880-144F1AEB-34B5-44F0-BB8C-63DB8B0F9A0FQ33692054-AE95BCC1-B494-4AC3-845D-7BF1BBD2F1B9Q33768779-8E8D963E-3C74-41B0-8C42-AECD18073363Q35542264-2A694803-D0FD-45C9-8C17-D1F1B05FE192Q35631782-F81D8B7D-C628-4C98-98C9-19BE9F304D6FQ35838588-065A971A-9FDA-49D5-80CC-3A5AEBC094E7Q35868819-3C995F8E-79B1-40BE-9050-8C7E8C2B008CQ36057957-05AB4ED0-B982-4E87-BA35-F60B33B7C4C2Q36172403-5D3AE5D4-B9DD-48A5-B159-4BA4A0FB8011Q36964270-D09C92C8-BAF5-424F-A7FA-1634D607F77DQ37140198-7C70E3F9-CF58-4F9E-92A6-323FA04E1765Q37623666-6F309084-EC60-4822-944D-8AB2D99463DCQ38262325-D4020644-1B1C-49E1-BA34-68891BABA237Q38369003-505D4B6B-4255-47E0-BF57-1674C3A96C84Q38398014-913CAD49-D411-49F6-84CD-120772D4B8ACQ38406325-DA99EC7B-C906-4F6E-A5B5-0308171B708CQ38524254-3125431B-C67C-42B0-8A74-60C1A68764D9Q38547886-B40D6966-109D-451F-A8BE-27BB96331964Q38605644-ED149AAF-7104-467F-9A8B-20B475183333Q38635568-D9672B96-8576-4342-BD7B-E9FE2961A1CBQ38693172-EA5032D4-CC0C-4B92-8F94-DD7DEE33E7C9Q38723866-24DA389B-21B2-40CC-83FB-BE05C79562EEQ38728496-EDE32C8D-9AD2-4A27-9288-FC667B4BB44CQ38779161-6EC9AF09-5640-4AAA-B1D1-0346A61ACEE5Q38784172-A9198F45-6B21-49AD-AA93-905F22D48BCEQ38802398-0A983502-32AE-47DB-BA91-6AA6A5D3D62CQ38826010-7D3462E2-2AEF-4192-8CD3-83207C654F6FQ38860492-420B68BC-3BC4-4DD1-A0AB-2782EABD21E7Q38975409-150A69FA-4172-4F53-A280-4DF48B2AB266Q39285809-1E09F98E-3254-4680-BD12-73899A8C1C23Q39584450-43A11F1C-D3BC-4857-A288-85FF766CE75EQ39900127-7F309067-4294-4203-BF92-C5E455CF450D
P2860
Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) P
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Periprocedural stroke and blee ...... in Atrial Fibrillation (AF) P
@en
type
label
Periprocedural stroke and blee ...... in Atrial Fibrillation (AF) P
@en
prefLabel
Periprocedural stroke and blee ...... in Atrial Fibrillation (AF) P
@en
P2093
P50
P921
P1433
P1476
Periprocedural stroke and blee ...... ion (COMPARE) randomized trial
@en
P2093
Andrea Natale
Antonio Rossillo
Claude S Elayi
Claudio Tondo
Dhanunjaya Lakkireddy
G Joseph Gallinghouse
Gaetano Fassini
Gemma Pelargonio
Giovanni Forleo
P304
P356
10.1161/CIRCULATIONAHA.113.006426
P407
P577
2014-04-17T00:00:00Z